{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:06:45Z","timestamp":1789718805065,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA276212"],"award-info":[{"award-number":["R01CA276212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA276212"],"award-info":[{"award-number":["R01CA276212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA276212"],"award-info":[{"award-number":["R01CA276212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA276212"],"award-info":[{"award-number":["R01CA276212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1471\/2017, AC"],"award-info":[{"award-number":["NMRC\/CIRG\/1471\/2017, AC"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1471\/2017, AC"],"award-info":[{"award-number":["NMRC\/CIRG\/1471\/2017, AC"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1471\/2017, AC"],"award-info":[{"award-number":["NMRC\/CIRG\/1471\/2017, AC"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1471\/2017, AC"],"award-info":[{"award-number":["NMRC\/CIRG\/1471\/2017, AC"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory signaling is linked with cancer-related cognitive impairment (CRCI), potentially through modulation of brain-derived neurotrophic factor (BDNF) expression. Here, we evaluate associations between plasma cytokines and BDNF and their relationship with cognition in a longitudinal study of adolescent and young adult cancer patients (AYAC) receiving chemotherapy and non-cancer controls (NC) (Clinicaltrials.gov: NCT03476070).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Newly diagnosed AYAC (15\u201339\u00a0years old) and age-matched NC completed the Functional Assessment of Cancer Therapy-Cognitive Function questionnaire (FACT\u2010Cog), the Cambridge Neuropsychological Test Automated Battery (CANTAB), and blood draws every 3\u20136\u00a0months up to 12\u00a0months (AYAC) or 6\u00a0months (NC) from baseline. Plasma levels of cytokines and BDNF were quantified using a multiplexed immunoassay and ELISA, respectively. Biomarker-cognition and cytokine-BDNF associations were analyzed using mixed-effects models with interactions for chemotherapy status for AYAC (during chemotherapy vs.\u2009&gt;\u200930\u00a0days post-chemotherapy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One-hundred and seventy-seven participants were included, with 66 AYAC and 111 NC. AYAC had a higher frequency of clinically significant cognitive impairment during and post-chemotherapy compared to NC. In trends unique to AYAC, higher IL-10 was associated with better self-perceived cognition, IL-8 with better multi-tasking, IL-6 with worse multi-tasking, response speed, and attention, and TNF-\u03b1 with better memory (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Higher BDNF was associated with better memory and response speed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). IL-4, IL-10, TNF-\u03b1, and IFN-\u03b3 were associated with BDNF levels among AYAC and NC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our large, age-matched study implicates dysregulated cytokine signaling and altered BDNF expression in CRCI among AYAC during and post-chemotherapy. As precision medicine becomes integrated into AYA patient care, plasma BDNF and cytokines may serve as important predictors of CRCI onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was prospectively registered on ClinicalTrials.gov (NCT03476070) on March 3, 2018.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-14430-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T02:47:21Z","timestamp":1751338041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brain-derived neurotrophic factor and cytokines as predictors of cognitive impairment in adolescent and young adult cancer patients receiving chemotherapy: a longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"Julia","family":"Trudeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding Quan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"7","key":"14430_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(10)70294-1.","journal-title":"Lancet Oncol"},{"issue":"4","key":"14430_CR2","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1002\/cam4.5295","volume":"12","author":"A Chan","year":"2023","unstructured":"Chan A, Cheng I, Wang C, et al. Cognitive impairment in adolescent and young adult cancer patients: pre-treatment findings of a longitudinal study. Cancer Med. 2023;12(4):4821\u201331. https:\/\/doi.org\/10.1002\/cam4.5295.","journal-title":"Cancer Med"},{"issue":"5","key":"14430_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050687","volume":"11","author":"B Olson","year":"2019","unstructured":"Olson B, Marks DL. Pretreatment cancer-related cognitive impairment-mechanisms and outlook. Cancers (Basel). 2019;11(5): 687. https:\/\/doi.org\/10.3390\/cancers11050687.","journal-title":"Cancers (Basel)"},{"key":"14430_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.toxrep.2023.04.015","volume":"10","author":"LC Murillo","year":"2023","unstructured":"Murillo LC, Sutachan JJ, Albarrac\u00edn SL. An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI). Toxicol Rep. 2023;10:544\u201353. https:\/\/doi.org\/10.1016\/j.toxrep.2023.04.015.","journal-title":"Toxicol Rep"},{"key":"14430_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155653","volume":"148","author":"K Oppegaard","year":"2021","unstructured":"Oppegaard K, Harris CS, Shin J, et al. Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways. Cytokine. 2021;148: 155653. https:\/\/doi.org\/10.1016\/j.cyto.2021.155653.","journal-title":"Cytokine"},{"issue":"12","key":"14430_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081234","volume":"8","author":"YT Cheung","year":"2013","unstructured":"Cheung YT, Lim SR, Ho HK, Chan A. Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One. 2013;8(12): e81234. https:\/\/doi.org\/10.1371\/journal.pone.0081234.","journal-title":"PLoS One"},{"key":"14430_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577196","volume":"342","author":"YL Toh","year":"2020","unstructured":"Toh YL, Wang C, Ho HK, Chan A. Distinct cytokine profiles across trajectories of self-perceived cognitive impairment among early-stage breast cancer survivors. J Neuroimmunol. 2020;342: 577196. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577196.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"14430_CR8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Ng T, Shwe M, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol. 2015;26(7):1446\u201351. https:\/\/doi.org\/10.1093\/annonc\/mdv206.","journal-title":"Ann Oncol"},{"issue":"2","key":"14430_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/2772432817666220304212456","volume":"18","author":"K Tyagi","year":"2023","unstructured":"Tyagi K, Masoom M, Majid H, et al. Role of cytokines in chemotherapy-related cognitive impairment of breast cancer patients: a systematic review. Curr Rev Clin Exp Pharmacol. 2023;18(2):110\u20139. https:\/\/doi.org\/10.2174\/2772432817666220304212456.","journal-title":"Curr Rev Clin Exp Pharmacol"},{"issue":"4","key":"14430_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.21234","volume":"104","author":"CA Meyers","year":"2005","unstructured":"Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104(4):788\u201393. https:\/\/doi.org\/10.1002\/cncr.21234.","journal-title":"Cancer"},{"key":"14430_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2016.11.002","volume":"301","author":"DE Lyon","year":"2016","unstructured":"Lyon DE, Cohen R, Chen H, et al. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol. 2016;301:74\u201382. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.11.002.","journal-title":"J Neuroimmunol"},{"issue":"0","key":"14430_CR12","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","volume":"30 Suppl","author":"S Kesler","year":"2013","unstructured":"Kesler S, Janelsins M, Koovakkattu D, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30 Suppl(0):S109-116. https:\/\/doi.org\/10.1016\/j.bbi.2012.05.017.","journal-title":"Brain Behav Immun"},{"key":"14430_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.nlm.2014.08.008","volume":"115","author":"EJ Donzis","year":"2014","unstructured":"Donzis EJ, Tronson NC. Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences. Neurobiol Learn Mem. 2014;115:68\u201377. https:\/\/doi.org\/10.1016\/j.nlm.2014.08.008.","journal-title":"Neurobiol Learn Mem"},{"issue":"1","key":"14430_CR14","doi-asserted-by":"publisher","first-page":"16298","DOI":"10.1038\/s41598-023-43581-1","volume":"13","author":"DQ Ng","year":"2023","unstructured":"Ng DQ, Cheng I, Wang C, et al. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients. Sci Rep. 2023;13(1):16298. https:\/\/doi.org\/10.1038\/s41598-023-43581-1.","journal-title":"Sci Rep"},{"key":"14430_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1188672","volume":"17","author":"T Charlton","year":"2023","unstructured":"Charlton T, Prowse N, McFee A, et al. Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia. Front Cell Neurosci. 2023;17: 1188672. https:\/\/doi.org\/10.3389\/fncel.2023.1188672.","journal-title":"Front Cell Neurosci"},{"key":"14430_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103748","volume":"176","author":"DQ Ng","year":"2022","unstructured":"Ng DQ, Chan D, Agrawal P, et al. Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: a systematic review of human studies. Crit Rev Oncol Hematol. 2022;176: 103748. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103748.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"14430_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10549-020-05807-y","volume":"183","author":"NY Yap","year":"2020","unstructured":"Yap NY, Tan NYT, Tan CJ, et al. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer. Breast Cancer Res Treat. 2020;183(3):683\u201396. https:\/\/doi.org\/10.1007\/s10549-020-05807-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"14430_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbi.2005.04.005","volume":"20","author":"Z Guan","year":"2006","unstructured":"Guan Z, Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 2006;20(1):64\u201371. https:\/\/doi.org\/10.1016\/j.bbi.2005.04.005.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"14430_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2007.09.067","volume":"429","author":"S Schnydrig","year":"2007","unstructured":"Schnydrig S, Korner L, Landweer S, et al. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett. 2007;429(1):69\u201373. https:\/\/doi.org\/10.1016\/j.neulet.2007.09.067.","journal-title":"Neurosci Lett"},{"key":"14430_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155556","volume":"144","author":"NY Yap","year":"2021","unstructured":"Yap NY, Toh YL, Tan CJ, Acharya MM, Chan A. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment. Cytokine. 2021;144: 155556. https:\/\/doi.org\/10.1016\/j.cyto.2021.155556.","journal-title":"Cytokine"},{"key":"14430_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1069439","volume":"15","author":"S Leonardo","year":"2023","unstructured":"Leonardo S, Fregni F. Association of inflammation and cognition in the elderly: a systematic review and meta-analysis. Front Aging Neurosci. 2023;15: 1069439. https:\/\/doi.org\/10.3389\/fnagi.2023.1069439.","journal-title":"Front Aging Neurosci"},{"key":"14430_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2015.08.012","volume":"287","author":"CF Jehn","year":"2015","unstructured":"Jehn CF, Becker B, Flath B, et al. Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression. J Neuroimmunol. 2015;287:88\u201392. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.012.","journal-title":"J Neuroimmunol"},{"key":"14430_CR23","unstructured":"Closing the gap: research and care imperatives for adolescents and young adults with cancer. In: Report of the adolescent and young adult oncology progress review group. National Cancer Institute; 2006. https:\/\/www.cancer.gov\/types\/aya\/research\/ayao-august-2006.pdf."},{"issue":"8","key":"14430_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/pon.5456","volume":"29","author":"CJ Tan","year":"2020","unstructured":"Tan CJ, Mah JJJ, Goh WL, Poon E, Harunal Rashid MF, Chan A. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers. Psychooncology. 2020;29(8):1355\u201362. https:\/\/doi.org\/10.1002\/pon.5456.","journal-title":"Psychooncology"},{"issue":"19","key":"14430_CR25","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1200\/JCO.2011.39.6333","volume":"30","author":"HM Parsons","year":"2012","unstructured":"Parsons HM, Harlan LC, Lynch CF, et al. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012;30(19):2393\u2013400. https:\/\/doi.org\/10.1200\/JCO.2011.39.6333.","journal-title":"J Clin Oncol"},{"issue":"8","key":"14430_CR26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/pon.5980","volume":"31","author":"LM Vizer","year":"2022","unstructured":"Vizer LM, Mikles SP, Piepmeier AT. Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: a scoping review. Psychooncology. 2022;31(8):1275\u201385. https:\/\/doi.org\/10.1002\/pon.5980.","journal-title":"Psychooncology"},{"issue":"3","key":"14430_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/07347332.2024.2444276","volume":"43","author":"S Sharma","year":"2025","unstructured":"Sharma S, Brunet J. Cognitive impairment in young adults after cancer treatment: a descriptive correlational study on levels and associations with disease-related, psychological, and lifestyle factors. J Psychosoc Oncol. 2025;43(3):462\u201376. https:\/\/doi.org\/10.1080\/07347332.2024.2444276.","journal-title":"J Psychosoc Oncol"},{"key":"14430_CR28","unstructured":"Cambridge Cognition. Cambridge Neuropsychological Test Automated Battery (CANTAB). https:\/\/cambridgecognition.com\/digital-cognitive-assessments\/. Accessed 1 Feb 2023."},{"issue":"7","key":"14430_CR29","first-page":"399","volume":"85","author":"BJ Sahakian","year":"1992","unstructured":"Sahakian BJ, Owen AM. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med. 1992;85(7):399\u2013402.","journal-title":"J R Soc Med"},{"issue":"3","key":"14430_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/13803390802169059","volume":"31","author":"GH Maassen","year":"2009","unstructured":"Maassen GH, Bossema E, Brand N. Reliable change and practice effects: outcomes of various indices compared. J Clin Exp Neuropsychol. 2009;31(3):339\u201352. https:\/\/doi.org\/10.1080\/13803390802169059.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"14430_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1037\/0022-006x.59.1.12","volume":"59","author":"NS Jacobson","year":"1991","unstructured":"Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12\u20139. https:\/\/doi.org\/10.1037\/0022-006x.59.1.12.","journal-title":"J Consult Clin Psychol"},{"key":"14430_CR32","unstructured":"FACIT Group. Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). 2009. https:\/\/www.facit.org\/measures\/FACT-Cog. Accessed 1 Feb 2023."},{"key":"14430_CR33","unstructured":"Wagner LI, Sweet J, Butt Z, Lai JS, Cella D. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7(6):W32\u2013W39."},{"issue":"6","key":"14430_CR34","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jval.2013.06.017","volume":"16","author":"YT Cheung","year":"2013","unstructured":"Cheung YT, Lim SR, Shwe M, Tan YP, Chan A. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health. 2013;16(6):1001\u201313. https:\/\/doi.org\/10.1016\/j.jval.2013.06.017.","journal-title":"Value Health"},{"issue":"7","key":"14430_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jclinepi.2013.12.011","volume":"67","author":"YT Cheung","year":"2014","unstructured":"Cheung YT, Foo YL, Shwe M, et al. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. J Clin Epidemiol. 2014;67(7):811\u201320. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.12.011.","journal-title":"J Clin Epidemiol"},{"issue":"1\u20132","key":"14430_CR36","first-page":"36","volume":"15","author":"JC Pendergrass","year":"2018","unstructured":"Pendergrass JC, Targum SD, Harrison JE. Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci. 2018;15(1\u20132):36\u201344.","journal-title":"Innov Clin Neurosci"},{"issue":"2","key":"14430_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11764-015-0476-5","volume":"10","author":"JE Schmidt","year":"2016","unstructured":"Schmidt JE, Beckjord E, Bovbjerg DH, et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv. 2016;10(2):302\u201311. https:\/\/doi.org\/10.1007\/s11764-015-0476-5.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"14430_CR38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/bjc.1990.434","volume":"62","author":"J De Haes","year":"1990","unstructured":"De Haes J, Van Knippenberg F, Neijt J. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer. 1990;62(6):1034\u20138. https:\/\/doi.org\/10.1038\/bjc.1990.434.","journal-title":"Br J Cancer"},{"key":"14430_CR39","unstructured":"de Haes J, Olschewski M, Fayers P, et al. The Rotterdam Symptom Checklist (RSCL): a manual. 2012. https:\/\/meetinstrumentenzorg.nl\/wp-content\/uploads\/instrumenten\/RSCL-handl.pdf."},{"issue":"9","key":"14430_CR40","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1007\/s00520-018-4189-y","volume":"26","author":"A Chan","year":"2018","unstructured":"Chan A, Poon E, Goh WL, et al. Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal study. Support Care Cancer. 2018;26(9):3257\u201366. https:\/\/doi.org\/10.1007\/s00520-018-4189-y.","journal-title":"Support Care Cancer"},{"issue":"1","key":"14430_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpainsymman.2003.06.003","volume":"27","author":"KD Stein","year":"2004","unstructured":"Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27(1):14\u201323. https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.06.003.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"14430_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12955-018-0846-6","volume":"16","author":"A Chan","year":"2018","unstructured":"Chan A, Lew C, Wang XJ, et al. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore. Health Qual Life Outcomes. 2018;16(1):20. https:\/\/doi.org\/10.1186\/s12955-018-0846-6.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"14430_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.14336\/AD.2017.0717","volume":"9","author":"T Shen","year":"2018","unstructured":"Shen T, You Y, Joseph C, et al. BDNF polymorphism: a review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis. 2018;9(3):523. https:\/\/doi.org\/10.14336\/AD.2017.0717.","journal-title":"Aging Dis"},{"issue":"1","key":"14430_CR44","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s12885-017-3861-9","volume":"17","author":"T Ng","year":"2017","unstructured":"Ng T, Lee YY, Chae JW, et al. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study. BMC Cancer. 2017;17(1):867. https:\/\/doi.org\/10.1186\/s12885-017-3861-9.","journal-title":"BMC Cancer"},{"issue":"10","key":"14430_CR45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/cncr.34701","volume":"129","author":"V Puthenpura","year":"2023","unstructured":"Puthenpura V, Ji L, Xu X, et al. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: a report from the Children\u2019s Oncology Group. Cancer. 2023;129(10):1547\u201356. https:\/\/doi.org\/10.1002\/cncr.34701.","journal-title":"Cancer"},{"issue":"3","key":"14430_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11764-011-0173-y","volume":"5","author":"LC Harlan","year":"2011","unstructured":"Harlan LC, Lynch CF, Keegan THM, et al. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011;5(3):305\u201314. https:\/\/doi.org\/10.1007\/s11764-011-0173-y.","journal-title":"J Cancer Surviv"},{"key":"14430_CR47","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2024. Available from: https:\/\/www.R-project.org\/."},{"issue":"4","key":"14430_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/neurosci4040024","volume":"4","author":"N Keetile","year":"2023","unstructured":"Keetile N, Osuch E, Lentoor AG, Rasakanya T. Association of circulating levels of inflammatory cytokines and chemotherapy-associated subjective cognitive impairment in a South African cohort of breast cancer patients. NeuroSci. 2023;4(4):296\u2013304. https:\/\/doi.org\/10.3390\/neurosci4040024.","journal-title":"NeuroSci"},{"issue":"1","key":"14430_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13058-024-01850-5","volume":"26","author":"M Duivon","year":"2024","unstructured":"Duivon M, Lequesne J, Di Meglio A, et al. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study. Breast Cancer Res. 2024;26(1):93. https:\/\/doi.org\/10.1186\/s13058-024-01850-5.","journal-title":"Breast Cancer Res"},{"issue":"15","key":"14430_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Science. 2021;8(15): 2004433. https:\/\/doi.org\/10.1002\/advs.202004433.","journal-title":"Adv Science"},{"key":"14430_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fphys.2016.00509","volume":"7","author":"C Cabral-Santos","year":"2016","unstructured":"Cabral-Santos C, Castrill\u00f3n CIM, Miranda RAT, et al. Inflammatory cytokines and BDNF response to high-intensity intermittent exercise: effect the exercise volume. Front Physiol. 2016;7:7. https:\/\/doi.org\/10.3389\/fphys.2016.00509.","journal-title":"Front Physiol."},{"issue":"1","key":"14430_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5498\/wjp.v12.i1.77","volume":"12","author":"GA Porter","year":"2022","unstructured":"Porter GA, O\u2019Connor JC. Brain-derived neurotrophic factor and inflammation in depression: pathogenic partners in crime? WJP. 2022;12(1):77\u201397. https:\/\/doi.org\/10.5498\/wjp.v12.i1.77.","journal-title":"WJP"},{"issue":"4","key":"14430_CR53","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5765\/jkacap.230043","volume":"34","author":"J Jang","year":"2023","unstructured":"Jang J, Kim BJ, Lee CS, et al. Association between depressed mood changes and physical activity among adolescents post COVID-19 pandemic. J Korean Acad Child Adolesc Psychiatry. 2023;34(4):242\u20139. https:\/\/doi.org\/10.5765\/jkacap.230043.","journal-title":"J Korean Acad Child Adolesc Psychiatry"},{"key":"14430_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1305790","volume":"15","author":"S Tan","year":"2023","unstructured":"Tan S, Chen W, Kong G, Wei L, Xie Y. Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications. Front Aging Neurosci. 2023;15: 1305790. https:\/\/doi.org\/10.3389\/fnagi.2023.1305790.","journal-title":"Front Aging Neurosci"},{"key":"14430_CR55","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"6","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. AOMS. 2015;6:1164\u201378. https:\/\/doi.org\/10.5114\/aoms.2015.56342.","journal-title":"AOMS"},{"issue":"6","key":"14430_CR56","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012075","volume":"12","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Ehrlich BE. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med. 2020;12(6): e12075. https:\/\/doi.org\/10.15252\/emmm.202012075.","journal-title":"EMBO Mol Med"},{"key":"14430_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.770413","volume":"8","author":"Z Orsz\u00e1ghov\u00e1","year":"2021","unstructured":"Orsz\u00e1ghov\u00e1 Z, Mego M, Chovanec M. Long-term cognitive dysfunction in cancer survivors. Front Mol Biosci. 2021;8: 770413. https:\/\/doi.org\/10.3389\/fmolb.2021.770413.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"14430_CR58","doi-asserted-by":"publisher","first-page":"648","DOI":"10.6004\/jnccn.2024.0062","volume":"22","author":"T Sanft","year":"2024","unstructured":"Sanft T, Day AT, Goldman M, et al. NCCN guidelines\u00ae insights: survivorship, version 2.2024: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network. 2024;22(10):648\u201358. https:\/\/doi.org\/10.6004\/jnccn.2024.0062.","journal-title":"Journal of the National Comprehensive Cancer Network."},{"key":"14430_CR59","doi-asserted-by":"publisher","unstructured":"Smoak P, Flores V, Harman N, Lisano J, Hayward R, Stewart L. Structured exercise in cancer survivors: is it enough for neural, mental health and well-being? Int J Exerc Sci. 2021;14(3). https:\/\/doi.org\/10.70252\/AJQK9649.","DOI":"10.70252\/AJQK9649"},{"issue":"3","key":"14430_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/RNN-201060","volume":"39","author":"H Huang","year":"2021","unstructured":"Huang H, Li W, Qin Z, Shen H, Li X, Wang W. Physical exercise increases peripheral brain-derived neurotrophic factors in patients with cognitive impairment: a meta-analysis. Restor Neurol Neurosci. 2021;39(3):159\u201371. https:\/\/doi.org\/10.3233\/RNN-201060.","journal-title":"Restor Neurol Neurosci"},{"issue":"3","key":"14430_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14030194","volume":"14","author":"DGM Kaagman","year":"2024","unstructured":"Kaagman DGM, Van Wegen EEH, Cignetti N, Rothermel E, Vanbellingen T, Hirsch MA. Effects and mechanisms of exercise on Brain-Derived Neurotrophic Factor (BDNF) levels and clinical outcomes in people with Parkinson\u2019s disease: a systematic review and meta-analysis. Brain Sci. 2024;14(3): 194. https:\/\/doi.org\/10.3390\/brainsci14030194.","journal-title":"Brain Sci"},{"issue":"3","key":"14430_CR62","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s13311-022-01339-z","volume":"20","author":"MT Usmani","year":"2023","unstructured":"Usmani MT, Krattli RP, El-Khatib SM, et al. BDNF augmentation using riluzole reverses doxorubicin-induced decline in cognitive function and neurogenesis. Neurotherapeutics. 2023;20(3):838\u201352. https:\/\/doi.org\/10.1007\/s13311-022-01339-z.","journal-title":"Neurotherapeutics"},{"issue":"9\u201310","key":"14430_CR63","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/jocn.16201","volume":"32","author":"HC Hong","year":"2023","unstructured":"Hong HC, Min A, Kim YM. A systematic review and pooled prevalence of symptoms among childhood and adolescent and young adult cancer survivors. J Clin Nurs. 2023;32(9\u201310):1768\u201394. https:\/\/doi.org\/10.1111\/jocn.16201.","journal-title":"J Clin Nurs"},{"issue":"4","key":"14430_CR64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1089\/jayao.2019.0157","volume":"9","author":"A Smrke","year":"2020","unstructured":"Smrke A, Leung B, Srikanthan A, McDonald M, Bates A, Ho C. Distinct features of psychosocial distress of adolescents and young adults with cancer compared to adults at diagnosis: patient-reported domains of concern. J Adolesc Young Adult Oncol. 2020;9(4):540\u20135. https:\/\/doi.org\/10.1089\/jayao.2019.0157.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"17","key":"14430_CR65","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1002\/cncr.33634","volume":"127","author":"X Ji","year":"2021","unstructured":"Ji X, Cummings JR, Mertens AC, Wen H, Effinger KE. Substance use, substance use disorders, and treatment in adolescent and young adult cancer survivors-results from a national survey. Cancer. 2021;127(17):3223\u201331. https:\/\/doi.org\/10.1002\/cncr.33634.","journal-title":"Cancer"},{"issue":"1","key":"14430_CR66","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.1038\/s41598-023-44798-w","volume":"13","author":"A Shafiee","year":"2023","unstructured":"Shafiee A, Jafarabady K, Rafiei MA, et al. Effect of alcohol on Brain-Derived Neurotrophic Factor (BDNF) blood levels: a systematic review and meta-analysis. Sci Rep. 2023;13(1):17554. https:\/\/doi.org\/10.1038\/s41598-023-44798-w.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14430-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14430-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T02:47:23Z","timestamp":1751338043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14430-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14430"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14430-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethics approval from the SingHealth Centralized Institutional Review Board (CIRB 2017\/3139) and informed consent was obtained prior to study participation (ClinicalTrials.gov: NCT03476070). All experiments were performed in accordance with relevant human subject guidelines and regulations, including ethical principles outlined in the Belmont Report and legal mandates outlined in Singapore\u2019s Human Biomedical Research Act (HBRA) and the International Conference for Harmonization Guidelines for Good Clinical Practice (ICH GCP).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1045"}}